1. Home
  2. BORR vs ABCL Comparison

BORR vs ABCL Comparison

Compare BORR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

HOLD

Current Price

$3.97

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.59

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BORR
ABCL
Founded
2016
2012
Country
Bermuda
Canada
Employees
N/A
596
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
BORR
ABCL
Price
$3.97
$3.59
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
$3.75
$7.75
AVG Volume (30 Days)
5.8M
3.1M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
0.50%
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$1,024,500,000.00
$35,325,000.00
Revenue This Year
$1.03
$25.45
Revenue Next Year
$1.76
$10.07
P/E Ratio
$14.18
N/A
Revenue Growth
5.83
7.17
52 Week Low
$1.55
$1.89
52 Week High
$4.48
$6.52

Technical Indicators

Market Signals
Indicator
BORR
ABCL
Relative Strength Index (RSI) 58.62 44.29
Support Level $3.58 $3.32
Resistance Level $3.34 $3.82
Average True Range (ATR) 0.21 0.19
MACD -0.03 0.06
Stochastic Oscillator 41.67 51.85

Price Performance

Historical Comparison
BORR
ABCL

About BORR Borr Drilling Limited

Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: